Revolutionize Your Operations Embrace Xentria Inc's Cutting-Edge Technology

Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs. With this funding, the company advance the Xentria pipeline and execute against the goal of developing critical therapeutics for patients in ... Xentria, Inc., a clinical-stage biotherapeutics company focused on developing therapeutics to address unmet clinical needs, today announced ... Essential stats, news, real-time insights on Xentria, Inc.. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews. ... Xentria, Inc. | Not yet recruiting ➔ Enrolling by invitation. Enrollment open • Immunology • Sarcoidosis. Print; Email; More sharing. Reddit · StumbleUpon. Keymed Biosciences Co.Ltd · Fondazione Policlinico Universitario Agostino Gemelli... Terminado · Xentria, Inc. Terminado · Serum Institute of India ... Xentria, Inc. Research summary. Study XTMAB-16-202 is a long term extension study that will be run at approximately 38 sites in the ... Vice President, Clinical Development - Xentria, Inc. · Solutions-focused clinical development professional with a diverse background in patient care, ... Xentria is is an innovative biopharmaceutics company whose primary focus is to build an expansive product pipeline of therapeutics to address. Xentria will transfer the XTMAB-16 intellectual property to Meitheal's parent company, King Friend Industry, if the royalties pass $600 million.